A pharmaceutical composition is described for the prevention and treatment of external otitis or otitis media, in particular in the veterinary field. The composition of the invention comprises a synergistic association of N-acetylcysteine and a stabilizing agent, which has been shown to be significantly active against pathogens causing the external otitis, at the same time significantly reducing the disadvantages of N-acetylcysteine.
展开▼